Supplemental Disclosure for Statements of Cash Flows (Details) (USD $)
|
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2014
|
Dec. 31, 2013
|
Dec. 31, 2012
|
|
Cash paid during the period for interest | $ 2,900,000us-gaap_InterestPaid | $ 1,900,000us-gaap_InterestPaid | $ 647,000us-gaap_InterestPaid |
Issued stock for payment of milestone fee, shares | 100,000navb_StockIssuedDuringPeriodSharesIssuedforMilestoneFee | ||
Issued stock to 401(k) plan, shares | 36,455navb_StockIssuedDuringPeriodSharesFourZeroOneKContribution | 22,126navb_StockIssuedDuringPeriodSharesFourZeroOneKContribution | 17,390navb_StockIssuedDuringPeriodSharesFourZeroOneKContribution |
Issued stock for payment of sublicense fee, shares | 300,000us-gaap_StockIssuedDuringPeriodSharesIssuedForNoncashConsideration | ||
Portion of insurance premiums financed | 267,000navb_PortionOfInsurancePremiumsFinanced | ||
Interest rate stated percentage | 2.80%us-gaap_DebtInstrumentInterestRateStatedPercentage | ||
Equipment acquired under capital lease agreement | 9,000us-gaap_CapitalLeasedAssetsGross | ||
Repayments of notes payable | 25,000,000us-gaap_RepaymentsOfNotesPayable | 5,982,155us-gaap_RepaymentsOfNotesPayable | 1,285,046us-gaap_RepaymentsOfNotesPayable |
Platinum Montaur Life Sciences Llc Credit Facility [Member] | |||
Interest rate stated percentage |
10.00%us-gaap_DebtInstrumentInterestRateStatedPercentage / us-gaap_DebtInstrumentAxis = navb_PlatinumMontaurLifeSciencesLlcCreditFacilityMember |
||
Repayments of notes payable |
4,800,000us-gaap_RepaymentsOfNotesPayable / us-gaap_DebtInstrumentAxis = navb_PlatinumMontaurLifeSciencesLlcCreditFacilityMember |
||
General Electric Capital Corporation [Member] | |||
Estimated fair value of warrants issued |
631,000us-gaap_WarrantsAndRightsOutstanding / us-gaap_DebtInstrumentAxis = navb_GeneralElectricCapitalCorporationMember |
||
Deferred debt discount fees |
3,000,000navb_DeferredDebtDiscountFees / us-gaap_DebtInstrumentAxis = navb_GeneralElectricCapitalCorporationMember |
1,000,000navb_DeferredDebtDiscountFees / us-gaap_DebtInstrumentAxis = navb_GeneralElectricCapitalCorporationMember |
|
Crede CG III, Ltd. [Member] | |||
Estimated fair value of warrants issued |
7,700,000us-gaap_WarrantsAndRightsOutstanding / us-gaap_DebtInstrumentAxis = navb_CredeCGIIILtd.Member |
||
Oxford Finance, LLC [Member] | |||
Estimated fair value of warrants issued |
$ 465,000us-gaap_WarrantsAndRightsOutstanding / us-gaap_DebtInstrumentAxis = navb_OxfordFinanceLLCMember |
||
Series B Preferred Stock [Member] | |||
Conversion of Series B preferred stock to common stock, shares |
2,364.9us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities / us-gaap_StatementClassOfStockAxis = us-gaap_SeriesBPreferredStockMember |
X | ||||||||||
- Definition
Deferred debt discount fees No definition available.
|
X | ||||||||||
- Definition
Portion Of Insurance Premiums Financed. No definition available.
|
X | ||||||||||
- Definition
Stock Issued During Period, Shares, 401(k) Contribution No definition available.
|
X | ||||||||||
- Definition
Stock Issued During Period, Shares, Issued for Milestone Fee No definition available.
|
X | ||||||||||
- Definition
Amount before accumulated depreciation of leased physical assets used in the normal conduct of business to produce goods and services. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Contractual interest rate for funds borrowed, under the debt agreement. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The amount of cash paid for interest during the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The cash outflow for a borrowing supported by a written promise to pay an obligation. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Number of shares issued during the period as a result of the conversion of convertible securities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Number of shares issued for noncash consideration for development stage entities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|